Experimental immunotherapy may help patients with high-risk bladder cancer avoid bladder removal surgery

A Mayo Clinic-led international phase 3 study found that a new immunotherapy helped many patients with an aggressive form of bladder cancer keep their bladder instead of having it surgically removed. The treatment also kept many patients cancer-free for more than two years and caused mostly mild side effects. The findings were published in The Lancet Oncology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup